Moreover, the effect of LDL on SERPINE2 expression was reverted by blocking the entry of LDL into tumor cells, using an anti-LDLR antibody, and sequestering cholesterol using nystatin (Fig. 2F—right panel and Supp. Here, LDLR is linked to neoplasm.